価格表

在庫・価格 : 2024年05月18日 08時15分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Human SOX17 MAb (Clone 245013)
データシート※最新のデータシートでない場合があります
MAB1924-SP RSDアールアンドディー システムス
R&D Systems, Inc.
25 μg ¥30,000
(未発注)
追加

在庫・価格 : 2024年05月18日 08時15分 現在

Anti-Human SOX17 MAb (Clone 245013)

  • 商品コード:MAB1924-SP
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥30,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Zhu YJ et al. Generation of an induced pluripotent stem cell line (PUMCHi006-A) derived from a patient with pulmonary arterial hypertension carrying heterozygous c.1339 G > A mutation in PTGIS gene. Stem Cell Res 2020 12;49:102088
Zhu YJ et al
2020/01/01
Species: Human, Applications: ICC PubMed
2 Gao X et al. Establishment of human induced pluripotent stem cell line (CPGHi002-A) from a 10-month-old female patient with DDOD syndrome carrying a heterozygous c.1516 C > T mutation in ATP6V1B2. Stem Cell Res 2020 10;48:101986
Gao X et al
2020/01/01
Species: Human, Applications: ICC PubMed
3 Ohta E et al. Generation of gene-corrected iPSCs line (KEIUi001-A) from a PARK8 patient iPSCs with familial Parkinson"s disease carrying the I2020T mutation in LRRK2. Stem Cell Res 2020 12;49:102073
Ohta E et al
2020/01/01
Species: Human, Applications: ICC PubMed
4 Gao X et al. Generation of an iPSC line (GWCMCi002-A) from an X-linked Alport syndrome patient with a hemizygous splicing mutation (NM_000495.4, c. 1517-1 G > T) in the COL4A5 gene. Stem Cell Res 2021 05;53:102388
Gao X et al
2021/01/01
Species: Human, Applications: ICC PubMed
5 Gao X et al. Generation of a gene corrected human isogenic iPSC line (CPGHi002-A-1) from a DDOD patient with heterozygous c.1516 C>T mutation in the ATP6V1B2 gene. Stem Cell Res 2021 05;53:102271
Gao X et al
2021/01/01
Species: Human, Applications: Flow Cytometry PubMed
6 Fischer I et al. Generation of human induced pluripotent stem cell lines from 2 patients with MIRAGE syndrome. Stem Cell Res 2021 07;54:102417
Fischer I et al
2021/01/01
Species: Human, Applications: Flow Cytometry PubMed
7 Li N et al. An induced pluripotent stem cell line (GZHMCi004-A) derived from a fetus with heterozygous G380R mutation in FGFR3 gene causing achondroplasia. Stem Cell Res 2021 05;53:102322
Li N et al
2021/01/01
Species: Human, Applications: Flow Cytometry PubMed
8 Jia N et al. Generation of an induced pluripotent stem cell line (OGHFUi001-A) from a type 1 early infantile epileptic encephalopathy with ARX mutation. Stem Cell Res 2021 05;53:102367
Jia N et al
2021/01/01
Species: Human, Applications: ICC PubMed
9 Gao X et al. Derivation of an induced pluripotent stem cell line (GWCMCi001-A) from PBMCs of a four-year-old male patient with Immunoglobulin A nephropathy. Stem Cell Res 2020 Dec;50:102123
Gao X et al
2020/01/01
Species: Human, Applications: Flow Cytometry PubMed
10 Zhou HM et al. An induced pluripotent stem cell line (SHEHi002-A (5426))from a patient of long QT syndrome type 8 with c.2573G>A mutation in the gene CACNA1C. Stem Cell Res 2020 03;43:101731
Zhou HM et al
2020/01/01
Species: Human, Applications: ICC PubMed
11 Li J et al. Generation of a human induced pluripotent stem cell line (CPGHi003-A) from an auditory neuropathy patient with AIFM1 p.R422Q mutation. Stem Cell Res 2021 05;53:102376
Li J et al
2021/01/01
Species: Human, Applications: Flow Cytometry PubMed
12 Zheng Z et al. Generation of an induced pluripotent stem cell line (CHFUi001-A) from an osteogenesis imperfecta patient with COL1A2 mutation. Stem Cell Res 2020 Jul;47:101907
Zheng Z et al
2020/01/01
Species: Human, Applications: ICC PubMed
  • No.: 1
  • 文献情報:
    Zhu YJ et al. Generation of an induced pluripotent stem cell line (PUMCHi006-A) derived from a patient with pulmonary arterial hypertension carrying heterozygous c.1339 G > A mutation in PTGIS gene. Stem Cell Res 2020 12;49:102088
    Zhu YJ et al
    2020/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Gao X et al. Establishment of human induced pluripotent stem cell line (CPGHi002-A) from a 10-month-old female patient with DDOD syndrome carrying a heterozygous c.1516 C > T mutation in ATP6V1B2. Stem Cell Res 2020 10;48:101986
    Gao X et al
    2020/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Ohta E et al. Generation of gene-corrected iPSCs line (KEIUi001-A) from a PARK8 patient iPSCs with familial Parkinson"s disease carrying the I2020T mutation in LRRK2. Stem Cell Res 2020 12;49:102073
    Ohta E et al
    2020/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Gao X et al. Generation of an iPSC line (GWCMCi002-A) from an X-linked Alport syndrome patient with a hemizygous splicing mutation (NM_000495.4, c. 1517-1 G > T) in the COL4A5 gene. Stem Cell Res 2021 05;53:102388
    Gao X et al
    2021/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Gao X et al. Generation of a gene corrected human isogenic iPSC line (CPGHi002-A-1) from a DDOD patient with heterozygous c.1516 C>T mutation in the ATP6V1B2 gene. Stem Cell Res 2021 05;53:102271
    Gao X et al
    2021/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Fischer I et al. Generation of human induced pluripotent stem cell lines from 2 patients with MIRAGE syndrome. Stem Cell Res 2021 07;54:102417
    Fischer I et al
    2021/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Li N et al. An induced pluripotent stem cell line (GZHMCi004-A) derived from a fetus with heterozygous G380R mutation in FGFR3 gene causing achondroplasia. Stem Cell Res 2021 05;53:102322
    Li N et al
    2021/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Jia N et al. Generation of an induced pluripotent stem cell line (OGHFUi001-A) from a type 1 early infantile epileptic encephalopathy with ARX mutation. Stem Cell Res 2021 05;53:102367
    Jia N et al
    2021/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Gao X et al. Derivation of an induced pluripotent stem cell line (GWCMCi001-A) from PBMCs of a four-year-old male patient with Immunoglobulin A nephropathy. Stem Cell Res 2020 Dec;50:102123
    Gao X et al
    2020/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Zhou HM et al. An induced pluripotent stem cell line (SHEHi002-A (5426))from a patient of long QT syndrome type 8 with c.2573G>A mutation in the gene CACNA1C. Stem Cell Res 2020 03;43:101731
    Zhou HM et al
    2020/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Li J et al. Generation of a human induced pluripotent stem cell line (CPGHi003-A) from an auditory neuropathy patient with AIFM1 p.R422Q mutation. Stem Cell Res 2021 05;53:102376
    Li J et al
    2021/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Zheng Z et al. Generation of an induced pluripotent stem cell line (CHFUi001-A) from an osteogenesis imperfecta patient with COL1A2 mutation. Stem Cell Res 2020 Jul;47:101907
    Zheng Z et al
    2020/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed